...
首页> 外文期刊>Journal of Neurochemistry: Offical Journal of the International Society for Neurochemistry >The formation of tau pathological phospho-epitopes in the axon is prevented by the dephosphorylation of selective sites in primary hippocampal neurons over-expressing human tau.
【24h】

The formation of tau pathological phospho-epitopes in the axon is prevented by the dephosphorylation of selective sites in primary hippocampal neurons over-expressing human tau.

机译:轴突中tau病理性磷酸表位的形成可通过过度表达人类tau的原代海马神经元中选择性位点的去磷酸化来防止。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

In tauopathies including Alzheimer's disease, the axonal microtubule-associated protein tau becomes hyperphosphorylated at pathological epitopes and accumulates in the somato-dendritic compartment. However, it remains unclear whether tau becomes phosphorylated at these epitopes in the somato-dendritic compartment and/or in the axon. In primary hippocampal neurons where human tau was over-expressed both in the somato-dendritic compartment and the axon, the pathological epitopes recognized by the antibodies AT8 (S199/S202/T205), AT100 (T212/S214/T217), and AT180 (T231/S235) were found in the somato-dendritic compartment but not in the axon where tau was either not phosphorylated (T205 and T217) or not simultaneously phosphorylated (T231 and S235) at sites included in the above epitopes. When transfected neurons were treated with the phosphatase inhibitor, okadaic acid, AT8, AT100 and AT180 epitopes were observed in the axon, indicating that tau was dephosphorylated at selective sites of pathological epitopes in this compartment. Expression of tau mutants where one phosphorylation site included in the above epitopes was mutated in alanine showed that the formation of one of these epitopes was not required for the formation of the two others in primary hippocampal neurons. All together our results indicate that in the somato-dendritic compartment, the kinase and phosphatase activity does not prevent the formation of pathological epitopes whereas in the axon, the amount of tau phosphorylated at the pathological epitopes is regulated by phosphatase activity, most likely that of phosphoserine/phosphothreonine phosphatase 2A, the major tau phosphatase. This indicates that if the pathological epitopes are initially formed in the axon in Alzheimer's disease brain, the activation of phosphatases could be an efficient way to abolish their generation.
机译:在包括阿尔茨海默氏病在内的多种疾病中,轴突微管相关蛋白tau在病理性表位上被过度磷酸化,并累积在体树突状区室中。但是,尚不清楚tau是否在体表树突状隔室和/或轴突中的这些表位上被磷酸化。在人tau在体树突状区室和轴突中都过表达的原代海马神经元中,病理表位被抗体AT8(S199 / S202 / T205),AT100(T212 / S214 / T217)和AT180(在体表树突状区室中发现T231 / S235,但在上述表位所包含的位点上tau未被磷酸化(T205和T217)或未被同时磷酸化(T231和S235)的轴突中则没有。当用磷酸酶抑制剂处理转染的神经元时,在轴突中观察到冈田酸,AT8,AT100和AT180表位,表明tau在该区室中病理表位的选择性位点被去磷酸化。在上述表位中包括一个磷酸化位点在丙氨酸中突变的tau突变体的表达表明,在原代海马神经元中不需要形成这些表位中的一个就可以形成另外两个表位。我们的所有结果表明,在树突状细胞区室中,激酶和磷酸酶活性不能阻止病理性表位的形成,而在轴突中,病理性表位磷酸化的tau的量受磷酸酶活性的调节,最有可能是磷酸丝氨酸/磷酸苏氨酸磷酸酶2A,主要的tau磷酸酶。这表明,如果病理抗原决定簇最初形成于阿尔茨海默氏病大脑的轴突中,磷酸酶的激活可能是消除其生成的有效途径。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号